|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.93 USD | +1.35% |
|
+5.29% | +21.74% |
| Market Cap | 9.72B 8.54B 7.94B 7.28B 13.69B 936B 13.9B 94.26B 36.83B 460B 36.48B 35.7B 1,591B | P/E 2026 * |
12.3x | P/E 2027 * | 9.43x |
|---|---|---|---|---|---|
| Enterprise Value | 11.04B 9.7B 9.02B 8.27B 15.55B 1,063B 15.79B 107B 41.84B 523B 41.45B 40.55B 1,807B | EV / Sales 2026 * |
6.25x | EV / Sales 2027 * | 4.95x |
| Free-Float |
98.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | +1.35% | ||
| 1 week | +5.29% | ||
| Current month | +4.68% | ||
| 1 month | +15.15% | ||
| 3 months | +25.35% | ||
| 6 months | +18.36% | ||
| Current year | +21.74% |
| 1 week | 76.82 |  | 82.99 |
| 1 month | 72.71 | | 82.99 |
| Current year | 61.32 | | 82.99 |
| 1 year | 57.68 | | 82.99 |
| 3 years | 32.83 | | 82.99 |
| 5 years | 29.85 | | 82.99 |
| 10 years | 8.18 | | 82.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% | ||
| 7/1/26 | Sell | Director | -1,625 | 0.0014% | ||
| 7/1/26 | Free | Executive/Senior Manager | 56,055 | 0.0473% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.35% | +5.29% | +39.41% | +91.60% | 9.72B | |
| +0.45% | +2.80% | +55.83% | +20.48% | 324B | |
| -0.07% | +2.09% | +22.76% | -11.68% | 68.88B | |
| +0.93% | -1.38% | +1.71% | -4.10% | 8.37B | |
| +1.13% | +1.51% | -20.98% | -4.73% | 4.32B | |
| -4.00% | +0.71% | -7.10% | +12.39% | 3.62B | |
| +4.90% | +5.79% | -39.25% | +19.34% | 3.83B | |
| -2.10% | -3.83% | +40.64% | +53.74% | 2.68B | |
| -4.07% | -2.45% | -3.76% | -17.52% | 2.04B | |
| -5.78% | +0.89% | -18.97% | +28.59% | 1.84B | |
| Average | -0.73% | +0.91% | +7.03% | +18.81% | 42.9B | |
| Weighted average by Cap. | +0.34% | +2.15% | +46.24% | +16.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.77B 1.55B 1.44B 1.32B 2.49B 170B 2.53B 17.15B 6.7B 83.69B 6.64B 6.49B 289B | 2B 1.76B 1.64B 1.5B 2.82B 193B 2.87B 19.44B 7.6B 94.9B 7.52B 7.36B 328B |
| Net income | 812M 713M 663M 609M 1.14B 78.2B 1.16B 7.88B 3.08B 38.45B 3.05B 2.98B 133B | 1.03B 908M 845M 775M 1.46B 99.59B 1.48B 10.03B 3.92B 48.96B 3.88B 3.8B 169B |
| Net Debt | 1.32B 1.16B 1.08B 991M 1.86B 127B 1.89B 12.83B 5.01B 62.61B 4.96B 4.86B 216B | 205M 180M 167M 154M 289M 19.73B 293M 1.99B 776M 9.7B 769M 752M 33.53B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$81.93 | +1.35% | 1,661,209 |
| 26-07-23 | US$80.84 | +3.88% | 1,751,413 |
| 26-07-22 | US$77.82 | -0.99% | 1,399,919 |
| 26-07-21 | US$78.60 | +1.96% | 1,273,027 |
| 26-07-20 | US$77.09 | -0.93% | 1,552,675 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
